Azolopyridine-2-on derivatives as lipase and phospholipase inhibitors

Details for Australian Patent Application No. 2006257022 (hide)

Owner Sanofi-Aventis

Inventors Petry, Stefan; Heuer, Hubert; Muller, Gunter; Tennagels, Norbert; Zoller, Gerhard

Agent Watermark

Pub. Number AU-A-2006257022

PCT Pub. Number WO2006/131231

Priority 10 2005 026 762.9 09.06.05 DE

Filing date 27 May 2006

Wipo publication date 14 December 2006

International Classifications

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/424 (2006.01) - condensed with heterocyclic ring systems, e.g. clavulanic acid

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/131231 Priority application(s): WO2006/131231

22 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257023-Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors

2006257017-Hydrophilic nanoparticles with functional surface groups, production and use thereof